Franklin Covey share price today
Franklin Covey Co. · FC · Consumer Staples · Education & Training Services · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists
Franklin Covey share price: $17.33 at the close on 4 November 2026, +16.4% in a year.
Franklin Covey Co.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.
The main question: the share price moved +16.4% in a year while yearly earnings per share moved −86.4%. The difference came from the market paying a higher multiple.
The price has been between phases. Over the last four quarters, results have been improving, and 282% of the last 3 years' profit came in as cash. What will decide it: whether earnings grow into a price that has already moved.
What is the Franklin Covey share price today?
Franklin Covey Co.'s share price was $17.33 at the close on 4 November 2026. That is 11.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $12 and $25, and at that close it sat 44% of the way up from that low.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). The phase helps read everything below.
Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 19 weeks running.
Nov 2026: $17.33, 11.5% below its 200-day average.
- Price $17.33
- 50-day avg $18.15
- 200-day avg $19.58
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 11 Jul 2025 | $19.87 | – | – |
| 18 Jul 2025 | $19.33 | – | – |
| 25 Jul 2025 | $20.36 | – | – |
| 1 Aug 2025 | $18.62 | – | – |
| 8 Aug 2025 | $18.85 | – | – |
| 15 Aug 2025 | $19.35 | – | – |
| 22 Aug 2025 | $19.97 | – | – |
| 29 Aug 2025 | $19.56 | – | – |
| 5 Sep 2025 | $19.32 | – | – |
| 12 Sep 2025 | $19.01 | – | – |
| 19 Sep 2025 | $19.75 | $19.48 | – |
| 26 Sep 2025 | $20.19 | $19.46 | – |
| 3 Oct 2025 | $19.55 | $19.39 | – |
| 10 Oct 2025 | $17.16 | $19.18 | – |
| 17 Oct 2025 | $17.65 | $19.06 | – |
| 24 Oct 2025 | $18.68 | $19.01 | – |
| 31 Oct 2025 | $16.98 | $18.82 | – |
| 7 Nov 2025 | $14.89 | $18.49 | – |
| 14 Nov 2025 | $14.99 | $18.07 | – |
| 21 Nov 2025 | $15.05 | $17.64 | – |
| 28 Nov 2025 | $15.72 | $17.32 | – |
| 5 Dec 2025 | $15.89 | $16.95 | – |
| 12 Dec 2025 | $16.63 | $16.64 | – |
| 19 Dec 2025 | $16.88 | $16.45 | – |
| 26 Dec 2025 | $17.08 | $16.41 | – |
| 2 Jan 2026 | $16.64 | $16.30 | – |
| 9 Jan 2026 | $18.96 | $16.26 | – |
| 16 Jan 2026 | $20.95 | $16.59 | – |
| 23 Jan 2026 | $20.77 | $16.99 | – |
| 30 Jan 2026 | $20.37 | $17.51 | – |
| 6 Feb 2026 | $19.49 | $18.01 | – |
| 13 Feb 2026 | $17.76 | $18.31 | – |
| 20 Feb 2026 | $14.92 | $18.34 | – |
| 27 Feb 2026 | $13.02 | $18.05 | – |
| 6 Mar 2026 | $12.34 | $17.65 | – |
| 13 Mar 2026 | $11.54 | $17.12 | – |
| 20 Mar 2026 | $12.19 | $16.59 | – |
| 27 Mar 2026 | $15.29 | $16.16 | – |
| 2 Apr 2026 | $23.32 | $15.90 | – |
| 10 Apr 2026 | $21.55 | $16.06 | – |
| 17 Apr 2026 | $23.58 | $16.35 | – |
| 24 Apr 2026 | $21.61 | $16.69 | $17.93 |
| 1 May 2026 | $21.48 | $17.12 | $17.97 |
| 8 May 2026 | $22.15 | $17.96 | $18.03 |
| 15 May 2026 | $20.49 | $18.80 | $18.06 |
| 22 May 2026 | $23.67 | $19.81 | $18.13 |
| 29 May 2026 | $23.72 | $20.76 | $18.23 |
| 5 Jun 2026 | $23.93 | $21.81 | $18.34 |
| 12 Jun 2026 | $24.32 | $22.68 | $18.46 |
| 18 Jun 2026 | $23.89 | $22.75 | $18.54 |
| 26 Jun 2026 | $24.84 | $22.89 | $18.66 |
| 2 Jul 2026 | $21.78 | $22.96 | $18.76 |
| 10 Jul 2026 | $20.97 | $22.88 | $18.79 |
| 17 Jul 2026 | $20.28 | $22.74 | $18.81 |
| 24 Jul 2026 | $20.60 | $22.62 | $18.86 |
| 31 Jul 2026 | $21.45 | $22.68 | $18.95 |
| 7 Aug 2026 | $21.81 | $22.53 | $19.05 |
| 14 Aug 2026 | $20.25 | $22.22 | $19.10 |
| 21 Aug 2026 | $20.29 | $21.79 | $19.17 |
| 28 Aug 2026 | $20.37 | $21.44 | $19.28 |
| 4 Sep 2026 | $19.02 | $21.01 | $19.38 |
| 11 Sep 2026 | $17.96 | $20.47 | $19.45 |
| 18 Sep 2026 | $17.27 | $20.11 | $19.51 |
| 25 Sep 2026 | $17.31 | $19.80 | $19.54 |
| 2 Oct 2026 | $17.33 | $19.43 | $19.56 |
| 9 Oct 2026 | $18.15 | $19.07 | $19.59 |
| 16 Oct 2026 | $17.95 | $18.75 | $19.62 |
| 23 Oct 2026 | $18.68 | $18.48 | $19.65 |
| 30 Oct 2026 | $18.10 | $18.34 | $19.63 |
| 4 Nov 2026 | $17.33 | $18.15 | $19.58 |
Week by week since 2025: did it beat the S&P 500 over the past 13 weeks?
Ahead in 19 of 57 weeks
| Week | 13-week return vs S&P 500 |
|---|---|
| 11 Jul 2025 | no S&P 500 reading |
| 18 Jul 2025 | no S&P 500 reading |
| 25 Jul 2025 | no S&P 500 reading |
| 1 Aug 2025 | no S&P 500 reading |
| 8 Aug 2025 | no S&P 500 reading |
| 15 Aug 2025 | no S&P 500 reading |
| 22 Aug 2025 | no S&P 500 reading |
| 29 Aug 2025 | no S&P 500 reading |
| 5 Sep 2025 | no S&P 500 reading |
| 12 Sep 2025 | no S&P 500 reading |
| 19 Sep 2025 | no S&P 500 reading |
| 26 Sep 2025 | no S&P 500 reading |
| 3 Oct 2025 | no S&P 500 reading |
| 10 Oct 2025 | −18.4% |
| 17 Oct 2025 | −14.6% |
| 24 Oct 2025 | −14.6% |
| 31 Oct 2025 | −18.5% |
| 7 Nov 2025 | −26.3% |
| 14 Nov 2025 | −27.0% |
| 21 Nov 2025 | −26.8% |
| 28 Nov 2025 | −25.6% |
| 5 Dec 2025 | −23.7% |
| 12 Dec 2025 | −16.2% |
| 19 Dec 2025 | −17.1% |
| 26 Dec 2025 | −19.7% |
| 2 Jan 2026 | −17.0% |
| 9 Jan 2026 | +4.2% |
| 16 Jan 2026 | +14.6% |
| 23 Jan 2026 | +9.4% |
| 30 Jan 2026 | +18.5% |
| 6 Feb 2026 | +28.0% |
| 13 Feb 2026 | +17.0% |
| 20 Feb 2026 | −5.5% |
| 27 Feb 2026 | −17.6% |
| 6 Mar 2026 | −20.4% |
| 13 Mar 2026 | −27.8% |
| 20 Mar 2026 | −23.1% |
| 27 Mar 2026 | −2.3% |
| 2 Apr 2026 | +44.1% |
| 10 Apr 2026 | +15.8% |
| 17 Apr 2026 | +9.9% |
| 24 Apr 2026 | +0.5% |
| 1 May 2026 | +1.3% |
| 8 May 2026 | +6.8% |
| 15 May 2026 | +6.9% |
| 22 May 2026 | +50.5% |
| 29 May 2026 | +71.9% |
| 5 Jun 2026 | +84.2% |
| 12 Jun 2026 | +98.7% |
| 18 Jun 2026 | +80.8% |
| 26 Jun 2026 | +47.5% |
| 2 Jul 2026 | −20.2% |
| 10 Jul 2026 | −13.8% |
| 17 Jul 2026 | −18.7% |
| 24 Jul 2026 | −8.2% |
| 31 Jul 2026 | −3.8% |
| 7 Aug 2026 | −6.4% |
| 14 Aug 2026 | −6.2% |
| 21 Aug 2026 | −17.0% |
| 28 Aug 2026 | −15.8% |
| 4 Sep 2026 | −24.9% |
| 11 Sep 2026 | −29.2% |
| 18 Sep 2026 | −29.7% |
| 25 Sep 2026 | −36.1% |
| 2 Oct 2026 | −23.8% |
| 9 Oct 2026 | −16.6% |
| 16 Oct 2026 | −14.2% |
| 23 Oct 2026 | −12.2% |
| 30 Oct 2026 | −16.8% |
| 4 Nov 2026 | −15.3% |
Over the last 1 year the share price moved −13% while the S&P 500 moved +18%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 26 June 2026. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What dividend does Franklin Covey pay?
Franklin Covey Co. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.
Which stock lists is Franklin Covey on?
Franklin Covey is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.
Is Franklin Covey profitable?
Franklin Covey Co. earned $3.1 M of net profit in the May 2026 quarter. Full-year FY25 profit was $3.1 M. Over 4 years profit has grown −31.1% a year on average. That is 4.5% of the quarter's revenue. The same quarter a year earlier lost $1.4 M. 4 of the last 12 reported quarters were loss-making.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
For the full year, FY25 profit was $3.1 M (−86.9% on the year before).
FY25 profit $3.1 M (−86.9% on the year before), −31.1% a year over 4 years
- Net profit $3.1 M
| Quarter | Net profit |
|---|---|
| FY21 | $13.6 M |
| FY22 | $18.4 M |
| FY23 | $17.8 M |
| FY24 | $23.4 M |
| FY25 | $3.1 M |
Growth on a year earlier
- Growth on a year earlier −86.9%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | 35.3% |
| FY23 | −3.5% |
| FY24 | 31.6% |
| FY25 | −86.9% |
May 2026: $3.1 M
- Net profit (quarterly) $3.1 M
| Quarter | Net profit (quarterly) |
|---|---|
| Aug 2023 | $6.8 M |
| Nov 2023 | $4.9 M |
| Feb 2024 | $0.9 M |
| May 2024 | $5.7 M |
| Aug 2024 | $12.0 M |
| Nov 2024 | $1.2 M |
| Feb 2025 | −$1.1 M |
| May 2025 | −$1.4 M |
| Aug 2025 | $4.4 M |
| Nov 2025 | −$3.3 M |
| Feb 2026 | −$2.0 M |
| May 2026 | $3.1 M |
Growth on a year earlier
- Growth on a year earlier −378.5%
| Quarter | Growth on a year earlier |
|---|---|
| Aug 2023 | 22.1% |
| Nov 2023 | 3.9% |
| Feb 2024 | −49.7% |
| May 2024 | 25.4% |
| Aug 2024 | 75.5% |
| Nov 2024 | −75.7% |
| Feb 2025 | −223.1% |
| May 2025 | −124.6% |
| Aug 2025 | −63.4% |
| Nov 2025 | −378.5% |
| Feb 2026 | – |
| May 2026 | – |
How much revenue does Franklin Covey make, and is it growing?
Franklin Covey Co. reported $67.8 M of revenue in the May 2026 quarter, +1.0% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 4 years it has grown 4.5% a year on average. The last full year, FY25, came in at $267 M.
Revenue is everything the company billed its customers in the period.
The last four reported quarters add to $263 M.
FY25 revenue was $267 M, −7.0% on the year before.
FY25 revenue $267 M (−7.0% on the year before), 4.5% a year over 4 years
- Revenue $267 M
| Quarter | Revenue |
|---|---|
| FY21 | $224 M |
| FY22 | $263 M |
| FY23 | $281 M |
| FY24 | $287 M |
| FY25 | $267 M |
Growth on a year earlier
- Growth on a year earlier −7%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | 17.3% |
| FY23 | 6.7% |
| FY24 | 2.4% |
| FY25 | −7% |
May 2026: $67.8 M (+1.0% on a year earlier), the 2nd quarter in a row of growth
- Revenue (quarterly) $67.8 M
| Quarter | Revenue (quarterly) |
|---|---|
| Aug 2023 | $78.0 M |
| Nov 2023 | $68.4 M |
| Feb 2024 | $61.3 M |
| May 2024 | $73.4 M |
| Aug 2024 | $84.1 M |
| Nov 2024 | $69.1 M |
| Feb 2025 | $59.6 M |
| May 2025 | $67.1 M |
| Aug 2025 | $71.2 M |
| Nov 2025 | $64.0 M |
| Feb 2026 | $59.6 M |
| May 2026 | $67.8 M |
Growth on a year earlier
- Growth on a year earlier 1%
| Quarter | Growth on a year earlier |
|---|---|
| Aug 2023 | −1.1% |
| Nov 2023 | −1.4% |
| Feb 2024 | −0.7% |
| May 2024 | 2.7% |
| Aug 2024 | 7.9% |
| Nov 2024 | 1% |
| Feb 2025 | −2.8% |
| May 2025 | −8.5% |
| Aug 2025 | −15.3% |
| Nov 2025 | −7.3% |
| Feb 2026 | 0.1% |
| May 2026 | 1% |
Recent pace: the last four quarters grew −5.4% on average, against 4.5% a year over the longer run, so this year is growing slower than its own long-run rate.
Is growth speeding up? Revenue over the last 12 months grew −6.1%, against −3.3% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −79.5%, against −65.4% a year (rolling over).
How much of every $100 of sales does Franklin Covey keep?
Franklin Covey Co.'s operating margin was 7.4% in the May 2026 quarter, 3.0 percentage points higher than the same quarter a year ago. Across 5 years it has been between 3.8% and 12.9%. The latest quarter is within that range.
Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
Why the margin moved: operating margin changed +3.0 percentage points on the year while gross margin changed −2.6 points. So the gain came mostly from the gross margin, which means input costs and prices charged.
FY25: 4.7%, within a range of 3.8% to 12.9% over 5 years
- Operating margin 4.7%
| Quarter | Operating margin |
|---|---|
| FY21 | 3.8% |
| FY22 | 9% |
| FY23 | 9.8% |
| FY24 | 12.9% |
| FY25 | 4.7% |
Change on the year before (points)
- Change on the year before (points) −8.2 pts
| Quarter | Change on the year before (points) |
|---|---|
| FY21 | – |
| FY22 | +5.2 pts |
| FY23 | +0.8 pts |
| FY24 | +3.1 pts |
| FY25 | −8.2 pts |
May 2026: operating margin 7.4% (+3.0 points on a year earlier)
- Operating margin 7.4%
| Quarter | Operating margin |
|---|---|
| Aug 2023 | 14.3% |
| Nov 2023 | 8.6% |
| Feb 2024 | 6.7% |
| May 2024 | 12.3% |
| Aug 2024 | 21.3% |
| Nov 2024 | 5% |
| Feb 2025 | −2.4% |
| May 2025 | 4.4% |
| Aug 2025 | 11.1% |
| Nov 2025 | 0.7% |
| Feb 2026 | −0.1% |
| May 2026 | 7.4% |
Change on a year earlier (points)
- Change on a year earlier (points) +3.0 pts
| Quarter | Change on a year earlier (points) |
|---|---|
| Aug 2023 | +3.3 pts |
| Nov 2023 | −0.6 pts |
| Feb 2024 | +2.1 pts |
| May 2024 | +3.1 pts |
| Aug 2024 | +7.0 pts |
| Nov 2024 | −3.6 pts |
| Feb 2025 | −9.1 pts |
| May 2025 | −7.9 pts |
| Aug 2025 | −10.2 pts |
| Nov 2025 | −4.3 pts |
| Feb 2026 | +2.3 pts |
| May 2026 | +3.0 pts |
Is Franklin Covey's profit turning into cash?
Over the last 3 years, 282% of Franklin Covey Co.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $29.0 M of operating cash against $3.1 M of profit. After $8.3 M of spending on assets, $20.7 M was left over as free cash.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
FY25: operating cash $29.0 M against profit $3.1 M; 282% of 3 years' profit came in as cash
- Operating cash $29.0 M
- Net profit $3.1 M
- Free cash $20.7 M
| Quarter | Operating cash | Net profit | Free cash |
|---|---|---|---|
| FY21 | $46.2 M | $13.6 M | $44.6 M |
| FY22 | $52.3 M | $18.4 M | $49.1 M |
| FY23 | $35.7 M | $17.8 M | $31.2 M |
| FY24 | $60.3 M | $23.4 M | $56.6 M |
| FY25 | $29.0 M | $3.1 M | $20.7 M |
May 2026: operating cash $1.1 M = 36% of the quarter's profit
- Operating cash (quarterly) $1.1 M
| Quarter | Operating cash (quarterly) |
|---|---|
| Aug 2023 | $9.8 M |
| Nov 2023 | $17.4 M |
| Feb 2024 | $12.8 M |
| May 2024 | $8.2 M |
| Aug 2024 | $21.9 M |
| Nov 2024 | $14.1 M |
| Feb 2025 | −$1.4 M |
| May 2025 | $6.3 M |
| Aug 2025 | $9.9 M |
| Nov 2025 | $0.1 M |
| Feb 2026 | $16.3 M |
| May 2026 | $1.1 M |
Operating cash as % of profit
- Operating cash as % of profit 36%
| Quarter | Operating cash as % of profit |
|---|---|
| Aug 2023 | 144% |
| Nov 2023 | 359% |
| Feb 2024 | 1,462% |
| May 2024 | 143% |
| Aug 2024 | 183% |
| Nov 2024 | 1,198% |
| Feb 2025 | – |
| May 2025 | – |
| Aug 2025 | 227% |
| Nov 2025 | – |
| Feb 2026 | – |
| May 2026 | 36% |
Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.
What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.
Where does Franklin Covey's cash go?
Franklin Covey Co. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $16.5 M on assets over the last 3 years. Averaged over those years that is 2.1% of FY25 revenue a year.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.
Spending on assets: $16.5 M over the last 3 years.
FY25: capex $8.3 M, up from the year before
- Capex $8.3 M
| Quarter | Capex |
|---|---|
| FY21 | $1.6 M |
| FY22 | $3.2 M |
| FY23 | $4.5 M |
| FY24 | $3.7 M |
| FY25 | $8.3 M |
May 2026: capex $1.2 M in the quarter
- Capex (quarterly) $1.2 M
| Quarter | Capex (quarterly) |
|---|---|
| Aug 2023 | $1.0 M |
| Nov 2023 | $1.1 M |
| Feb 2024 | $0.6 M |
| May 2024 | $0.9 M |
| Aug 2024 | $1.1 M |
| Nov 2024 | $1.0 M |
| Feb 2025 | $1.3 M |
| May 2025 | $1.8 M |
| Aug 2025 | $4.2 M |
| Nov 2025 | $1.7 M |
| Feb 2026 | $1.0 M |
| May 2026 | $1.2 M |
Free cash
- Free cash $0.03
| Quarter | Free cash |
|---|---|
| Aug 2023 | $8.8 M |
| Nov 2023 | $16.4 M |
| Feb 2024 | $12.1 M |
| May 2024 | $7.3 M |
| Aug 2024 | $20.8 M |
| Nov 2024 | $13.1 M |
| Feb 2025 | −$2.6 M |
| May 2025 | $4.5 M |
| Aug 2025 | $5.7 M |
| Nov 2025 | −$1.6 M |
| Feb 2026 | $15.2 M |
| May 2026 | $0 |
In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.
What is Franklin Covey's P/E ratio, and how does it compare with its own history?
Franklin Covey Co.'s P/E is 41.3×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.
P/E 41.3× against a usual —: with too little history to compare
- P/E 100.2×
| Week | P/E |
|---|---|
| 11 Jul 2025 | 25.1× |
| 18 Jul 2025 | 24.4× |
| 25 Jul 2025 | 25.7× |
| 1 Aug 2025 | 23.5× |
| 8 Aug 2025 | 23.8× |
| 15 Aug 2025 | 24.4× |
| 22 Aug 2025 | 25.2× |
| 29 Aug 2025 | 24.7× |
| 5 Sep 2025 | 79.2× |
| 12 Sep 2025 | 77.9× |
| 19 Sep 2025 | 80.9× |
| 26 Sep 2025 | 82.8× |
| 3 Oct 2025 | 80.1× |
| 10 Oct 2025 | 70.3× |
| 17 Oct 2025 | 72.3× |
| 24 Oct 2025 | 76.6× |
| 31 Oct 2025 | 69.6× |
| 7 Nov 2025 | 61.0× |
| 14 Nov 2025 | 61.4× |
| 21 Nov 2025 | 61.7× |
| 28 Nov 2025 | 64.4× |
| 5 Dec 2025 | 65.1× |
| 12 Dec 2025 | 68.2× |
| 19 Dec 2025 | 69.2× |
| 26 Dec 2025 | 70.0× |
| 2 Jan 2026 | 68.2× |
| 9 Jan 2026 | 77.7× |
| 16 Jan 2026 | 85.9× |
| 23 Jan 2026 | 85.1× |
| 30 Jan 2026 | 83.5× |
| 6 Feb 2026 | 79.9× |
| 13 Feb 2026 | 72.8× |
| 20 Feb 2026 | 61.1× |
| 27 Feb 2026 | 53.4× |
| 6 Mar 2026 | 50.6× |
| 13 Mar 2026 | 47.3× |
| 20 Mar 2026 | 50.0× |
| 27 Mar 2026 | 62.7× |
| 2 Apr 2026 | 95.6× |
| 5 Jun 2026 | 138.3× |
| 12 Jun 2026 | 140.6× |
| 18 Jun 2026 | 138.1× |
| 26 Jun 2026 | 140.6× |
| 2 Jul 2026 | 125.9× |
| 10 Jul 2026 | 121.2× |
| 17 Jul 2026 | 117.2× |
| 24 Jul 2026 | 119.1× |
| 31 Jul 2026 | 124.0× |
| 7 Aug 2026 | 126.1× |
| 14 Aug 2026 | 117.0× |
| 21 Aug 2026 | 117.3× |
| 28 Aug 2026 | 117.8× |
| 4 Sep 2026 | 109.9× |
| 11 Sep 2026 | 103.8× |
| 18 Sep 2026 | 99.8× |
| 25 Sep 2026 | 100.1× |
| 2 Oct 2026 | 100.2× |
| 9 Oct 2026 | 104.9× |
| 16 Oct 2026 | 103.8× |
| 23 Oct 2026 | 108.0× |
| 30 Oct 2026 | 104.6× |
| 4 Nov 2026 | 100.2× |
Earnings per share, 12 months
- Earnings per share, 12 months $0.17
| Week | Earnings per share, 12 months |
|---|---|
| 11 Jul 2025 | – |
| 18 Jul 2025 | – |
| 25 Jul 2025 | – |
| 1 Aug 2025 | – |
| 8 Aug 2025 | – |
| 15 Aug 2025 | – |
| 22 Aug 2025 | – |
| 29 Aug 2025 | – |
| 5 Sep 2025 | – |
| 12 Sep 2025 | – |
| 19 Sep 2025 | – |
| 26 Sep 2025 | $0.24 |
| 3 Oct 2025 | $0.24 |
| 10 Oct 2025 | $0.24 |
| 17 Oct 2025 | $0.24 |
| 24 Oct 2025 | $0.24 |
| 31 Oct 2025 | $0.24 |
| 7 Nov 2025 | $0.24 |
| 14 Nov 2025 | $0.24 |
| 21 Nov 2025 | $0.24 |
| 28 Nov 2025 | $0.24 |
| 5 Dec 2025 | $0.24 |
| 12 Dec 2025 | $0.24 |
| 19 Dec 2025 | $0.24 |
| 26 Dec 2025 | $0.24 |
| 2 Jan 2026 | $0.24 |
| 9 Jan 2026 | $0.24 |
| 16 Jan 2026 | $0.24 |
| 23 Jan 2026 | $0.24 |
| 30 Jan 2026 | $0.24 |
| 6 Feb 2026 | $0.24 |
| 13 Feb 2026 | $0.24 |
| 20 Feb 2026 | $0.24 |
| 27 Feb 2026 | $0.24 |
| 6 Mar 2026 | $0.24 |
| 13 Mar 2026 | $0.24 |
| 20 Mar 2026 | $0.24 |
| 27 Mar 2026 | $0.24 |
| 2 Apr 2026 | $0.24 |
| 5 Jun 2026 | $0.24 |
| 12 Jun 2026 | $0.24 |
| 18 Jun 2026 | $0.24 |
| 26 Jun 2026 | $0.17 |
| 2 Jul 2026 | $0.17 |
| 10 Jul 2026 | $0.17 |
| 17 Jul 2026 | $0.17 |
| 24 Jul 2026 | $0.17 |
| 31 Jul 2026 | $0.17 |
| 7 Aug 2026 | $0.17 |
| 14 Aug 2026 | $0.17 |
| 21 Aug 2026 | $0.17 |
| 28 Aug 2026 | $0.17 |
| 4 Sep 2026 | $0.17 |
| 11 Sep 2026 | $0.17 |
| 18 Sep 2026 | $0.17 |
| 25 Sep 2026 | $0.17 |
| 2 Oct 2026 | $0.17 |
| 9 Oct 2026 | $0.17 |
| 16 Oct 2026 | $0.17 |
| 23 Oct 2026 | $0.17 |
| 30 Oct 2026 | $0.17 |
| 4 Nov 2026 | $0.17 |
PEG 1.15 at the May 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
- PEG 1.15×
- PEG = 1.0 1.00×
| Quarter | PEG | PEG = 1.0 |
|---|---|---|
| Aug 2021 | 4.60× | 1.00× |
| Nov 2021 | 2.58× | 1.00× |
| Feb 2022 | 2.33× | 1.00× |
| May 2022 | 1.74× | 1.00× |
| Aug 2022 | 1.55× | 1.00× |
| Nov 2022 | 1.94× | 1.00× |
| Feb 2023 | 1.80× | 1.00× |
| May 2023 | 1.51× | 1.00× |
| Aug 2023 | 1.41× | 1.00× |
| Nov 2023 | 1.02× | 1.00× |
| Feb 2024 | 1.11× | 1.00× |
| May 2024 | 0.94× | 1.00× |
| Aug 2024 | 0.96× | 1.00× |
| Nov 2024 | 1.66× | 1.00× |
| Feb 2025 | 1.50× | 1.00× |
| May 2025 | 1.28× | 1.00× |
| Aug 2025 | 1.19× | 1.00× |
| Nov 2025 | 0.94× | 1.00× |
| Feb 2026 | 0.70× | 1.00× |
| May 2026 | 1.15× | 1.00× |
Why the multiple is where it is: over the past year earnings per share moved −86.4% while the price moved +16.4%. The price did better than earnings, which pushed the multiple up within its own range.
In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.
Is the Franklin Covey business getting better or worse?
Franklin Covey Co.'s business is giving mixed signals. Revenue, profit and EPS growth are shrinking while ROCE is still rising at 18.6%, so growth and returns point different ways. This is based on 12 quarters of 4 measures.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Growth year by year: revenue −7.0% in FY25, profit −86.9%
- Revenue growth −7.0%
| Quarter | Revenue growth |
|---|---|
| FY21 | – |
| FY22 | 17.3% |
| FY23 | 6.7% |
| FY24 | 2.4% |
| FY25 | −7% |
Profit growth, EPS growth
- Profit growth −86.9%
- EPS growth −86.4%
| Quarter | Profit growth | EPS growth |
|---|---|---|
| FY21 | – | – |
| FY22 | 35.3% | 32.3% |
| FY23 | −3.5% | −2.4% |
| FY24 | 31.6% | 40.3% |
| FY25 | −86.9% | −86.4% |
Three growth lines over twelve quarters: revenue stabilising, profit rolling over
- Revenue −6.1%
| Quarter | Revenue |
|---|---|
| Aug 2023 | 6.7% |
| Nov 2023 | 3.2% |
| Feb 2024 | 1.1% |
| May 2024 | −0.1% |
| Aug 2024 | 2.4% |
| Nov 2024 | 3% |
| Feb 2025 | 2.5% |
| May 2025 | −0.4% |
| Aug 2025 | −7% |
| Nov 2025 | −9% |
| Feb 2026 | −8.4% |
| May 2026 | −6.1% |
Profit, EPS
- Profit −79.5%
- EPS −78.2%
| Quarter | Profit | EPS |
|---|---|---|
| Aug 2023 | −3.5% | −3.6% |
| Nov 2023 | −6.8% | −4.4% |
| Feb 2024 | −10.7% | −8.2% |
| May 2024 | 10.3% | 16.1% |
| Aug 2024 | 31.6% | 39.9% |
| Nov 2024 | 9.8% | 14.5% |
| Feb 2025 | 4% | 8.6% |
| May 2025 | −41.7% | −40.8% |
| Aug 2025 | −86.9% | −86% |
| Nov 2025 | −107.1% | −107.9% |
| Feb 2026 | −113% | −115.6% |
| May 2026 | −79.5% | −78.2% |
ROCE: the return line, worked out each quarter
- ROCE 18.6%
| Quarter | ROCE |
|---|---|
| Aug 2023 | 27% |
| Nov 2023 | 27.3% |
| Feb 2024 | 28.8% |
| May 2024 | 34.8% |
| Aug 2024 | 38.2% |
| Nov 2024 | 38.3% |
| Feb 2025 | 33.9% |
| May 2025 | 26.9% |
| Aug 2025 | 13.9% |
| Nov 2025 | 11.7% |
| Feb 2026 | 16% |
| May 2026 | 18.6% |
Why it matters: when the lines disagree, each line above matters more than any single label.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | −7.0% | +0.5% | — | — |
| Profit | −86.9% | −45.0% | — | — |
| EPS | −86.4% | −42.8% | — | — |
| Stock price | +16.4% | — | — | — |
How much does Franklin Covey earn on its capital?
Franklin Covey Co. earned a ROE of 5% in FY25. Its return on capital used (ROIC) is 22.7 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 1.1% net margin and 1.10× asset turnover (sales divided by assets).
Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.
Why the return is what it is (FY25): a 1.1% net margin × 1.10× asset turnover × 3.63× leverage (assets divided by equity) ≈ 4.4% on equity. The margin does its share; borrowing is a big part of it.
The key test, return on capital used minus the cost of capital: 31.2% − 8.5% = +22.7 percentage points. The 8.5% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value.
The 31.2% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 14.8%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.
FY25: ROE 5%, the full history
- ROE 4.6%
- ROIC (annual) 14.8%
- Cost of capital 8.5%
| Quarter | ROE | ROIC (annual) | Cost of capital |
|---|---|---|---|
| FY21 | 17.1% | 12.8% | 8.5% |
| FY22 | 22.3% | 35.5% | 8.5% |
| FY23 | 22.6% | 37.1% | 8.5% |
| FY24 | 28.1% | 53.8% | 8.5% |
| FY25 | 4.6% | 14.8% | 8.5% |
May 2026: ROIC 20.8% (last 12 months) against a 8.5% cost of capital
- ROIC (12 months) 20.8%
- ROE (12 months) −17.2%
- Cost of capital 8.5%
| Quarter | ROIC (12 months) | ROE (12 months) | Cost of capital |
|---|---|---|---|
| Aug 2023 | 33.6% | 22% | 8.5% |
| Nov 2023 | 34.8% | 35.6% | 8.5% |
| Feb 2024 | 35.3% | 26% | 8.5% |
| May 2024 | 37.7% | 4.9% | 8.5% |
| Aug 2024 | 43.9% | 32% | 8.5% |
| Nov 2024 | 58.4% | 61.6% | 8.5% |
| Feb 2025 | 55% | 5.8% | 8.5% |
| May 2025 | 45.2% | −5.6% | 8.5% |
| Aug 2025 | 39.1% | −8.2% | 8.5% |
| Nov 2025 | 22.4% | 26.4% | 8.5% |
| Feb 2026 | 16.7% | −21.8% | 8.5% |
| May 2026 | 20.8% | −17.2% | 8.5% |
Does Franklin Covey have too much debt?
Franklin Covey Co. has total debt of $835 K against shareholder equity of $38.0 M as of Feb 2026, so its debt is 0.02× its equity, which is very little. Year by year, that ratio went from 0.41 in FY21 to 0.12 in FY25. So the returns on this page come from the business, not from borrowed money.
Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.
FY25: debt $7.8 M, 0.12× equity
- Total debt $7.8 M
| Quarter | Total debt |
|---|---|
| FY21 | $32.9 M |
| FY22 | $24.3 M |
| FY23 | $15.3 M |
| FY24 | $7.2 M |
| FY25 | $7.8 M |
Debt-to-equity
- Debt-to-equity 0.12×
| Quarter | Debt-to-equity |
|---|---|
| FY21 | 0.41× |
| FY22 | 0.29× |
| FY23 | 0.19× |
| FY24 | 0.09× |
| FY25 | 0.12× |
Feb 2026: debt $0.8 M, debt-to-equity 0.02
- Total debt (quarterly) $0.8 M
| Quarter | Total debt (quarterly) |
|---|---|
| May 2023 | $17.4 M |
| Aug 2023 | $15.3 M |
| Nov 2023 | $13.2 M |
| Feb 2024 | $11.1 M |
| May 2024 | $8.2 M |
| Aug 2024 | $7.2 M |
| Nov 2024 | $5.1 M |
| Feb 2025 | $4.2 M |
| May 2025 | $2.3 M |
| Aug 2025 | $7.8 M |
| Nov 2025 | $0.8 M |
| Feb 2026 | $0.8 M |
Debt-to-equity
- Debt-to-equity 0.02×
| Quarter | Debt-to-equity |
|---|---|
| May 2023 | 0.23× |
| Aug 2023 | 0.19× |
| Nov 2023 | 0.19× |
| Feb 2024 | 0.16× |
| May 2024 | 0.11× |
| Aug 2024 | 0.09× |
| Nov 2024 | 0.06× |
| Feb 2025 | 0.06× |
| May 2025 | 0.04× |
| Aug 2025 | 0.12× |
| Nov 2025 | 0.02× |
| Feb 2026 | 0.02× |
What is the Franklin Covey shareholding pattern?
8.8% of Franklin Covey Co.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 15.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.
There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.
It is a single reading at one point in time; we do not have its history.
Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.
How far is Franklin Covey from balance-sheet trouble?
For Franklin Covey Co., the Z-score is 3.01. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
Why it matters: a Z-score of 3.01 is well clear of the danger zone, so the balance sheet is not the risk here.
How does Franklin Covey rank in its industry?
44.2 out of 100, rank 12 of 20 in Education & Training Services, with 74% of the evidence available.
Franklin Covey Co. scores 44.2 out of 100 against the 20 companies it is compared with in Education & Training Services, ranking 12. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
The four parts add up to the total exactly: 13.7 + 15.3 + 6.8 + 8.4 = 44.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Franklin Covey compared with?
Franklin Covey ranks 12 of 20 Education & Training Services companies on the 4-Factor Sector Score, with 44.2 out of 100.
- 1New Oriental Education & Technology Group Inc.EDU · losing its lead · Most evidence points up · 81% evidence66.3out of 100
How the score adds up
Growth & earnings 22.9/35 · Revenue 15.5% · Profit 28% · Operating margin change 1.4 points · 83% evidenceCapital efficiency 11.0/25 · ROCE 13.1% · Operating margin 5.6% · 76% evidenceValuation 14.7/20 · P/E 15.3× · PEG 0.47 · 65% evidenceRelative strength 17.7/20 · Lead over its industry 5.6% · Lead over S&P 500 -2.5% · 1 year -0.9% · 100% evidence · 10 of 12 weeks aheadExact sum: 22.9 + 11 + 14.7 + 17.7 = 66.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 2Laureate Education, Inc.LAUR · quiet · Evidence leans up · 81% evidence63.6out of 100
How the score adds up
Growth & earnings 17.9/35 · Revenue 17.9% · Profit 25.4% · Operating margin change -0.6 points · 83% evidenceCapital efficiency 18.1/25 · ROCE 23.4% · Operating margin 36.3% · 76% evidenceValuation 14.2/20 · P/E 15.8× · PEG 0.5 · 65% evidenceRelative strength 13.4/20 · Lead over its industry 1.8% · Lead over S&P 500 -6.2% · 1 year 9.5% · 100% evidence · 2 of 12 weeks aheadExact sum: 17.9 + 18.1 + 14.2 + 13.4 = 63.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 3Stride, Inc.LRN · basing · Evidence leans up · 85% evidence63.2out of 100
How the score adds up
Growth & earnings 18.2/35 · Revenue 2.5% · Profit 6% · Operating margin change 2.1 points · 95% evidenceCapital efficiency 18.4/25 · ROCE 25.4% · Operating margin 13.6% · 76% evidenceValuation 13.4/20 · P/E 9.6× · PEG 0.81 · 65% evidenceRelative strength 13.2/20 · Lead over its industry -2.6% · Lead over S&P 500 -10.5% · 1 year 4% · 100% evidence · 0 of 12 weeks aheadExact sum: 18.2 + 18.4 + 13.4 + 13.2 = 63.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 4TAL Education GroupTAL · quiet · Evidence leans up · 71% evidence60.5out of 100
How the score adds up
Growth & earnings 29.2/35 · Revenue 32.4% · Profit 100% · Operating margin change 15.6 points · 83% evidenceCapital efficiency 9.2/25 · ROCE 8.7% · Operating margin 18.1% · 76% evidenceValuation 11.1/20 · P/E 6.5× · PEG — · 15% evidenceRelative strength 11.0/20 · Lead over its industry -2.6% · Lead over S&P 500 -10% · 1 year -13.2% · 100% evidence · 9 of 12 weeks aheadExact sum: 29.2 + 9.2 + 11.1 + 11 = 60.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 5Graham Holdings CompanyGHC · turning · Evidence leans up · 81% evidence58.8out of 100
How the score adds up
Growth & earnings 12.7/35 · Revenue 4.8% · Profit -20.6% · Operating margin change 10.9 points · 83% evidenceCapital efficiency 10.3/25 · ROCE 8% · Operating margin 19.7% · 76% evidenceValuation 16.0/20 · P/E 9.1× · PEG 0.29 · 65% evidenceRelative strength 19.8/20 · Lead over its industry 14.3% · Lead over S&P 500 5.5% · 1 year 16% · 100% evidence · 1 of 12 weeks aheadExact sum: 12.7 + 10.3 + 16 + 19.8 = 58.8 · What this means: Relative strength against the index is 5.5%, and revenue and profit growth are weak. - 6Covista Inc.CVSA · quiet · Evidence leans up · 81% evidence58.2out of 100
How the score adds up
Growth & earnings 18.4/35 · Revenue 9.2% · Profit 6.3% · Operating margin change 2.4 points · 83% evidenceCapital efficiency 16.1/25 · ROCE 16.1% · Operating margin 19.3% · 76% evidenceValuation 9.7/20 · P/E 16.9× · PEG 1.28 · 65% evidenceRelative strength 14.0/20 · Lead over its industry 3.9% · Lead over S&P 500 -4.3% · 1 year 19% · 100% evidence · 2 of 12 weeks aheadExact sum: 18.4 + 16.1 + 9.7 + 14 = 58.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 7Perdoceo Education CorporationPRDO · quiet · Evidence leans up · 81% evidence57.3out of 100
How the score adds up
Growth & earnings 19.5/35 · Revenue 11.7% · Profit 14.9% · Operating margin change 1.2 points · 83% evidenceCapital efficiency 18.2/25 · ROCE 18.1% · Operating margin 25.7% · 76% evidenceValuation 13.8/20 · P/E 11.3× · PEG 0.58 · 65% evidenceRelative strength 5.8/20 · Lead over its industry -13.3% · Lead over S&P 500 -20.2% · 1 year -11.9% · 100% evidence · 1 of 12 weeks aheadExact sum: 19.5 + 18.2 + 13.8 + 5.8 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 8Grand Canyon Education, Inc.LOPE · quiet · Evidence leans up · 81% evidence54.5out of 100
How the score adds up
Growth & earnings 18.3/35 · Revenue 7% · Profit -5.5% · Operating margin change 1.1 points · 83% evidenceCapital efficiency 21.0/25 · ROCE 39.6% · Operating margin 22% · 76% evidenceValuation 7.0/20 · P/E 16.7× · PEG 1.9 · 65% evidenceRelative strength 8.2/20 · Lead over its industry -18% · Lead over S&P 500 -24.3% · 1 year -26.4% · 100% evidence · 2 of 12 weeks aheadExact sum: 18.3 + 21 + 7 + 8.2 = 54.5 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. - 9Legacy Education Inc.LGCY · quiet · Evidence leans up · 81% evidence53.8out of 100
How the score adds up
Growth & earnings 22.3/35 · Revenue 21.5% · Profit 28.6% · Operating margin change 1.9 points · 83% evidenceCapital efficiency 15.1/25 · ROCE 17.8% · Operating margin 13% · 76% evidenceValuation 9.4/20 · P/E 16.3× · PEG 1.4 · 65% evidenceRelative strength 7.0/20 · Lead over its industry -12% · Lead over S&P 500 -19.1% · 1 year 11% · 100% evidence · 0 of 12 weeks aheadExact sum: 22.3 + 15.1 + 9.4 + 7 = 53.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 10Strategic Education, Inc.STRA · quiet · Evidence leans down · 81% evidence46.9out of 100
How the score adds up
Growth & earnings 17.6/35 · Revenue 3.5% · Profit 17.4% · Operating margin change 0.6 points · 83% evidenceCapital efficiency 12.3/25 · ROCE 11.2% · Operating margin 15.7% · 76% evidenceValuation 14.4/20 · P/E 12.7× · PEG 0.52 · 65% evidenceRelative strength 2.6/20 · Lead over its industry -22.3% · Lead over S&P 500 -28.4% · 1 year -23.1% · 100% evidence · 2 of 12 weeks aheadExact sum: 17.6 + 12.3 + 14.4 + 2.6 = 46.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 11American Public Education, Inc.APEI · quiet · Evidence leans down · 64% evidence46.3out of 100
- 12Franklin Covey Co. this pageFC · quiet · Evidence leans down · 74% evidence44.2out of 100
How the score adds up
Growth & earnings 13.7/35 · Revenue -6.1% · Profit -81.8% · Operating margin change 3 points · 62% evidenceCapital efficiency 15.3/25 · ROCE 23.1% · Operating margin 7.4% · 76% evidenceValuation 6.8/20 · P/E 122.3× · PEG 1.74 · 65% evidenceRelative strength 8.4/20 · Lead over its industry -2.8% · Lead over S&P 500 -10.7% · 1 year 16.4% · 100% evidence · 0 of 12 weeks aheadExact sum: 13.7 + 15.3 + 6.8 + 8.4 = 44.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 13Phoenix Education Partners, Inc.PXED · basing · Evidence leans down · 65% evidence43.9out of 100
- 14McGraw Hill, Inc.MH · losing its lead · Evidence leans down · 64% evidence42.9out of 100
- 15Coursera, Inc.COUR · quiet · Evidence leans down · 61% evidence42.6out of 100
- 16Lincoln Educational Services CorporationLINC · quiet · Evidence leans down · 81% evidence39.2out of 100
- 17KinderCare Learning Companies, Inc.KLC · basing · Too little evidence to rank firmly · 58% evidence30.6out of 100
- 18Universal Technical Institute, Inc.UTI · basing · Most evidence points down · 81% evidence29.0out of 100
- 19Neucleus Group LimitedNEUC · Too little evidence to rank firmly · 11% evidence57.2out of 100
- 20Chegg, Inc.CHGG · Too little evidence to rank firmly · 44% evidence43.2out of 100
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Education & Training Services, all 20 compared on one page.
Which companies are close to Franklin Covey in size?
Franklin Covey is the 20th largest of 20 Education & Training Services companies on Sector Alpha by market value (scores of 5 November 2026). Just above it: Afya, Phoenix Education Partners, Inc., American Public Education, Inc., Lincoln Educational Services Corporation, Gaotu Techedu Inc. and KinderCare Learning Companies, Inc. It is the smallest.
Education & Training Services companies close in size
- Afya Limited $929 million
- Phoenix Education Partners, Inc. $794 million
- American Public Education, Inc. $776 million
- Lincoln Educational Services Corporation $638 million
- Gaotu Techedu Inc. $552 million
- KinderCare Learning Companies, Inc. $254 million
- Franklin Covey Co. $196 million
All 20 Education & Training Services companies, largest first
What else do people ask about Franklin Covey?
What were Franklin Covey's latest quarterly results?
Franklin Covey Co. reported revenue of $67.8 M and net profit of $3.1 M for the May 2026 quarter. Earnings per share were $0.27. The operating margin was 7.4%, 3.0 percentage points higher than a year earlier (as of 4 November 2026).
What is Franklin Covey's market cap?
Franklin Covey Co.'s market capitalisation is $196 M at a stock price of $17.33. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).
How is Franklin Covey performing?
Franklin Covey Co.'s latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 19 weeks running. This describes what the data did, not a rating (as of 4 November 2026).
Will Franklin Covey's stock price go up?
This page does not forecast Franklin Covey Co.'s stock price. What it shows instead: the stock price is $17.33. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).
Where is Franklin Covey in its business cycle?
Franklin Covey Co.'s FY25 operating margin was 4.7%, against a 5-year range of 3.8% to 12.9%: the low end of its own range, which is often where recoveries start. The latest quarter was 7.4%.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).
What could break the Franklin Covey story?
The main question: the share price moved +16.4% in a year while yearly earnings per share moved −86.4%. The difference came from the market paying a higher multiple.
On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).
Is Franklin Covey a stock worth studying right now?
What the numbers show: Franklin Covey Co.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved.
Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
US stocks
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.